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Abstract
Background: The LightCyclerH Mycobacterium Detection Kit based on real-time PCR technology for the detection of
Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium kansasii was recently developed. This study evaluated
its analytical sensitivity, specificity and reproducibility.
Methodology/Principal Findings: Plasmid standards were prepared and used to determine the limit of detection. The assay
was also performed against organisms other than mycobacteria, other mycobacterial strains and interfering substances to
exclude cross-reactivity and interference. Reference standards were prepared and tested to assess the assay’s
reproducibility. All PCR assays were performed using the LightCyclerH 2.0 Instrument. The detection limit for M. tuberculosis
was 28 copies per microlitre. Neither cross-reactivity nor interference occurred with non-mycobacterial organisms and
substances tested. Overall reproducibility for consecutive measurements, run-to-run, lot-to-lot, day-to-day and laboratory-
to-laboratory achieved a coefficient of variance of less than two percent.
Significance: The LightCyclerH Mycobacterium Detection kit has shown to be a robust and accurate assay with the potential
to be used as a rapid TB diagnostic test.
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Introduction
In 2009, 5.8 million cases of tuberculosis were reported to the
national tuberculosis control programmes globally where only
57% of the globally notified pulmonary cases were smear positive.
Furthermore, the World Health Organization estimates that close
to 1.3 million people die as a consequence of the disease.
Therefore serious efforts are needed to strengthen the control of
tuberculosis [1].
The occurrence of nontuberculous mycobacteria (NTM) from
pulmonary samples is occurring with greater frequency driven
mainly by the high rates of people living with HIV [2]. The
commonest NTM’s associated with pulmonary infection are M.
avium complex, M. kansasii, M. abscessus and M. fortuitum [2–4].
Since tuberculosis is a disease for which the vaccine has failed to
provide complete protective immunity [5], its control has relied on
early diagnosis and treatment. However, smear microscopy which
is the primary tool has a low sensitivity and culture has a very
lengthy turnaround time despite its sensitivity [6]. Several nucleic
acid amplification tests are available and all aimed at improving
the diagnosis of tuberculosis [6–9]. However, none of these assays
have performed adequately to become the new standard for
diagnosis. Recently the XpertH MTB/Rif (Cepheid, USA) test,
based on real-time polymerase chain reaction (PCR), has received
WHO endorsement [10].
Real-time PCR provides great hope as it is a highly sensitive,
specific, and rapid molecular method. In addition, an assessment
of the dissociation-characteristics of double-stranded DNA during
heating known as melting curve analysis can provide species
identification [11–13]. The LightCyclerH System (Roche Diag-
nostics, Germany) has been widely used as a platform for real-time
PCR. This platform has the advantage of a high-throughput
capacity which is important in a high-burden setting.
A new commercial molecular diagnostic assay the LightCyclerH
Mycobacterium Detection Kit (Roche Products (Pty) Ltd, Randburg,
South Africa), was developed for use on respiratory samples. It is based
on the real-time PCR technology for the detection of M. tuberculosis,M.
avium and M. kansasii within 90 minutes and amplifies the 16s
ribosomal RNA (rRNA) gene which includes the hypervariable region
A. The products are detected using the fluorogenic hybridization
probes and species identification by melting curve analysis on the
LightCyclerH 2.0 (Roche Diagnostics, Germany). A synthetic internal
control has been integrated into the reaction. This study evaluated the
assay’s analytical sensitivity, specificity and reproducibility.
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This study was performed at 4 centres viz. the HELIOS
Klinikum E. v. Behring (Germany), Institute of Medical
Microbiology Hygiene - University of Regensburg (Germany),
Department of Medical Microbiology - University of Pretoria
(South Africa) and the National Health Laboratory Service -
Kimberley laboratory (South Africa).
These centres were involved in analytically evaluating the
LightCyclerH Mycobacterium Detection Kit by preparation of
plasmid standards to determine the limit of detection, a challenge
panel consisting of other mycobacterial species, non-mycobacterial
organisms and interfering substances to assess specificity and
mycobacterial standards to measure reproducibility. The assay’s
reproducibility in terms of consecutive measurements (intra-run),
run-to-run, day-to-day, lot-to-lot and laboratory-to-laboratory was
performed at the two South African centres only.
DNA extraction
Mycobacterial reference standards and simulated respiratory
samples were decontaminated using N-acetyl-L-cysteine-Sodium
hydroxide (NaLc-NaOH) [14] and resuspended in 1.5 ml of
phosphate buffer containing 0.5% Tween 80 which allowed better
homogenization and even distribution of the bacilli within the
suspension prior to extraction.
The COBASH Amplicor Respiratory Sample Preparation Kit
(Roche Diagnostics, Germany) was used according to the
manufacturer’s instructions. Briefly, a 100 ml aliquot of the
NALC-NaOH decontaminated sample was mixed with the kit’s
wash solution and centrifuged (14,0006 g for 10 min). After
centrifugation, the supernatant was removed and the lysis reagent
was added to the pellet. After brief vortexing, the suspension was
incubated at 60uC for 45 min to complete lysis of the
mycobacteria. Thereafter the neutralizing reagent was added
making a total volume of 200 ml neutralized DNA sample. Four
microlitres (4 ml) of the neutralized sample was used as template
DNA for subsequent PCR testing.
PCR assay
All PCR assays were performed using the LightCyclerH 2.0
(Roche, Germany) real-time instrument. For amplification and
detection, the LightCyclerH Mycobacterium Detection Kit (Roche
Diagnostics) was used according to the manufacturer’s instruc-
tions. Samples were amplified as follows: initial denaturation step
at 95uC for 10 min to activate the FastStart Taq DNA polymerase
and 45 cycles of denaturation at 95uC for 10 sec, annealing at
50uC for 10 sec, and an extension at 72uC for 20 sec.
Following the amplification phase, a melting curve analysis at
40uCt o6 5 uC was performed with a temperature transition rate of
0.1uC/sec to determine the melting temperature (Tm) values for
the sequences targeted by the hybridization probes. Tm values
were either automatically or manually assigned from a plot
generated by the instrument. A Tm of 53.5–56.5uC indicated M.
tuberculosis, 48–51uC M. avium and 57–60uC M. kansasii.
The generation of target amplicons for each sample was
monitored between the annealing and the elongation steps at
640 nm. Samples positive for the specific amplicon (an approx-
imate 200 bp fragment of the mycobacterial 16S rDNA) were
identified by the instrument at the cycle number where the
fluorescence attributable to the target sequences exceeded that
measured for background. Samples scored as positive by the
instrument were confirmed by visual inspection of the amplifica-
tion curve (cycle number versus fluorescence value) generated by
the instrument.
Analysis was performed after activation of the colour compen-
sation using the following steps: a positive control showing an
exponential amplification curve with a defined crossing point (CP)
value of ,26.5 with a signal intensity of .0.1; a positive control
showing a melting curve Tm value of ,57–60uC for M. kansasii with
a signalintensityof.0.1,a negative control showinganexponential
amplification curve for the internal control only (detection channel
705/back 530 nm only) with a defined CP value of ,30–34 with a
signal intensity of .0.1. Samples were regarded positive for
mycobacteria if they had exponential amplification with a CP
value of less than 35 with a signal intensity of .0.02 and negative
with no amplification on the 640/back 530 nm channel and
exponential amplification for the internal control in the 705/back
530 nm channel having a signal intensity of .0.02.
Preparation of Mycobacterial Reference Standards
M. tuberculosis, M. avium and M. kansasii clinical isolates were
cultured on 7H11 agar (Becton Dickinson, USA) for 2 weeks.
Homogenization of harvested bacteria was achieved by vortexing
with glass beads (2 mm) for 30 seconds followed by subsequent sub-
cultivation in 7H9 broth (Becton Dickinson, USA). Once culture
broths reached the logarithmic growth phase corresponding to a
McFarland 0.5 turbidity the broth was removed and dilution
standards prepared. The dilutions were further homogenized by
vortexing with glass beads. These bacterial suspensions contained
approximately 10
6 colony forming units per millilitre (CFU/ml).
Preparation of simulated respiratory samples
Samples of bronchoalveolar lavage (BAL) originating from
patients without any clinical signs or symptoms of tuberculosis or
other mycobacterial infections were used as template material for
preparation of the simulated respiratory samples for the repro-
ducibility study. The BAL samples were spiked with the prepared
mycobacterial reference standards. Culture of the spiked samples
yielded 13 000 CFU/ml for M. tuberculosis, 39 000 CFU/ml for M.
avium and 30 000 CFU/ml for M. kansasii. These stock solutions
were used to prepare the dilution series.
Analytical Sensitivity (Limit of Detection)
Plasmid standards using a single gene copy were used to
determine the Limit of Detection (LOD) of the assay. Plasmid
standards for M. tuberculosis were tested in a 6 fold dilution series:
130, 65, 33, 16, 7 and 2 copies per microlitre. All measurements
were performed in 20-fold replicates (5 replicates in 4 independent
runs on the same LightCyclerH Instrument and the same day). For
verification of the measurements the reference standards were run
in parallel on the FDA approved CobasH Amplicor Mycobacterium
Tuberculosis Test. The effect of interfering substances (table 1) on
PCR inhibition was also assessed.
Analytical specificity
In order to check for cross reactivity, a challenge panel was
prepared which consisted of other mycobacterial species and non-
mycobacterial organisms (table 1); this was tested in duplicate
using the LightCyclerH Mycobacterium Detection Kit. The concen-
trations of the template nucleic acids were determined by
photometric measurement and quantitative in-house PCR assays
[15]. The species identities of all bacterial and fungal strains were
verified by complete 16S rDNA sequencing.
Reproducibility Study
The reproducibility study was designed to measure the
variability of the Tm and CP measurements of the assay. For
Real-Time PCR for Mycobacterial Species
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tuberculosis at concentrations of 1625 cp/ml, 325 cp/ml, 65 cp/ml
and 13 cp/ml, M. avium at 4875 cp/ml, 487.5 cp/ml and 48.75 cp/
ml, and M. kansasii concentrations of 3750 cp/ml, 375 cp/ml and
37.5 cp/ml. In each run, these standards were tested in triplicate
for M. tuberculosis and duplicate for both M. avium and M. kansasii.
The study was performed at two laboratories; each using a single
technician, with a total of 60 runs completed over a 10 day period.
The reproducibility of consecutive measurements (intra-run), run-
to-run, day-to day, lot-to-lot and laboratory-to-laboratory was
measured. A coefficient of variance (CV) of less than ten percent
was expected.
Statistical analysis
The limit of detection (LOD) was determined by using the Probit
method,where,thenumberofpositiveresponseswereconvertedtoa
ratio for each of the test concentrations and fitted to a regression
model of binary response variables. The LOD was read off the
generated graph at the 95% probability for response. For the
determination of the measurement precision, the run-to-run, day-to-
day, lot-to-lot and laboratory-to-laboratory variation, a variance
component analysis for the crossing points (CP) and melting
temperatures (Tm) of M. tuberculosis, M. avium and M. kansasii at
different concentrations was carried out. The variance component
analysis was performed. All statistical analyses were carried out using
the statistical software package JMP 7.0 (SAS/STATH Software).
Results
Analytical Sensitivity (LOD)
Plasmid standards with the target gene were used to determine
the limit of detection of the assay. Based on Probit analysis the
LOD at the 0.95 (95%) probability for response was calculated at
28 copies per ml [95%CI: 19, 54] or 112 copies per reaction
[95%CI: 76, 216] (Figure 1). Furthermore, interfering substances
had no effect on PCR performance.
Analytical Specificity
For all non mycobacterial organism tested the specific primer
and probe set of the LightCyclerH Mycobacterium Detection Kit
showed no cross-reactivity with non-mycobacterial organisms.
However, two other mycobacterial species were detected M.
flavescens with a Tm around 50uC (expected for M. avium) and M.
scrofulaceum appeared with a melting point around 58uC (expected
for M. kansasii) and no cross-reactivity in the melting temperature
range for M. tuberculosis.
Reproducibility
The coefficient of variance for the CP and Tm values of M.
tuberculosis, M. avium and M. kansasii at different concentrations were
calculated. The Tm values for the run-to-run, day-to-day and lot-
to-lot had a coefficient of variance (CV) of less than 2%. The
majority of samples demonstrated CV’s below 0.4% (Table 2) with
a standard deviation of between 0.1–0.2uC. The highest variance
for the Tm of M. tuberculosis and M. avium occurred in the
laboratory-to-laboratory component due to three outliers at the
Pretoria site from a total of 760 measurements.
There was a variance in the mean Tm of approximately 0.3uC–
0.4uC across all the mycobacterial concentrations between the
Pretoria and Kimberley sites (Table 3). The standard deviation for
the Tm ranged between 0.1–0.2uC and these were independent of
sample concentrations. However, in a single measurement from
Table 1. Challenge organisms and interfering substances
used to determine the analytical sensitivity and specificity of
the test.
Organisms other than
Mycobacteria
Mycobacterial
organisms
Interfering
substances
Adenovirus DNA M. peregrinum Haemoglobin
HIV RNA M. marinum Ethambutol
Influenza A virus RNA M. gordonae Clarithromycin
Parainfluenza RNA M. flavescens Azithromycin
Aspergillus fumigatus M. engbaekii Isoniazid
Candida albicans M. smegmatis Rifampicin
Neisseria meningitidis M. neoaurum Pyrazinamid
Haemophilus inluenzae M. celatum
Moraxella catarhalis M. fortuitum
Moraxella osloensis M. ratisbonense
Bordetella pertussis M. kansasii
Escherichia coli M. simiae
Enterobacter cloacae M. malmoense
Klebsiella pneumoniae M. szulgai
Chlamydia trachomatis M. hasiaticum
Salmonella typhi M. bovis/H37
Proteus vulgaris M. terrae
Legionella pneumphila M. shimoidei
Acinetobacter baumanii M. xenopi
Pseudomonas aeruginosa M. phlei
Helicobacter pylori M. intracellulare
Nocardia asteroides M. scrofulaceum
Corynebacterium diphteria M. avium
Staphylococcus aureus M. chimerae
Legionella micdadei M. elephantis
Streptococcus Group C
Streptococcus Gruppe F
Streptococcus pneumoniae
Mycoplasma pneumoniae
doi:10.1371/journal.pone.0024789.t001
Figure 1. Probit analysis for determination of the Limit of
Detection.
doi:10.1371/journal.pone.0024789.g001
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melting temperature range of M. kansasii (57–60uC) (Figure 2).
The mean and standard deviation (SD) for the CP values were
dependent on the concentration of organisms within the samples
(table 3). At the higher concentrations the variance ranged from
0.22–1.02% with a SD range of 0.247–0.480 and at the lower
concentrations the variance ranged from 0.0–1.03% with a SD
range of 0.357–1.087 (table 2 & 3).
Discussion
Improved diagnostic tests for tuberculosis are urgently needed
and this has been demonstrated in several studies [8,16].
Diagnostics with better sensitivity and the ability to differentiate
between M. tuberculosis and non-tuberculous mycobacteria are
required. The application of nucleic acid amplification techniques
for tuberculosis diagnosis is promising as it can be done directly on
patient specimens with corresponding high sensitivity/specificity
and a rapid turnaround time. Real-time PCR provides an
advanced methodology due to its unique ability to monitor the
complete DNA amplification process and identify specific products
within the same reaction using fluorescence techniques. The initial
high cost of this technology has decreased considerably with the
continual improvement in their capability and accuracy [17].
This study showed the LightCyclerH Mycobacterium Detection kit
to be a robust and accurate assay. The limit of detection as low as
28 copies per microlitre (112 copies/reaction) is promising when
compared with other TB molecular assays although not as
sensitive as the XpertH MTB/Rif assay (Cepheid, USA) [18–20].
The assay has the potential of being used as a rapid TB diagnostic
in place of smear microscopy where resources are available. The
lack of sensitivity in comparison to the XpertH MTB/Rif assay
may be due to the initial specimen volume of a 100 mli n
comparison to the 1.5 ml used by the Cepheid system [20]. Studies
to evaluate changes in the input volume to improve test
performance are required.
This study was reproducible as it showed good performance
at two independent sites an academic laboratory and a routine
Table 2. Variance component analysis of the Crossing Point values and Melting temperature range.
CROSSING POINTS
Reference Standard
Intra Run
Variability
Run to Run
Variability
Day to Day
Variability
Lot to Lot
Variability
Lab to Lab
Variability
Repeatability Intermediate Precision Reproducibility
M. tuberculosis (325 cp/ml) SD: 0.371 SD: 0.303 SD: 0.102 SD: 0.003 SD: 0.180
CV: 1.21% CV: 0.99% CV: 0.33% CV: 0.01% CV: 0.59%
M. tuberculosis (1625 cp/ml) SD: 0.264 SD: 0.0 SD: 0.071 SD: 0.0 SD: 0.067
CV: 0.94% CV: 0.0% CV: 0.25% CV: 0.0% CV: 0.24%
M. avium (488 cp/ml) SD: 0.314 SD: 0.129 SD: 0.149 SD: 0.0 SD: 0.106
CV: 1.02% CV: 0.42% CV: 0.48% CV: 0.0% CV: 0.34%
M. avium (4875 cp/ml) SD: 0.290 SD: 0.0 SD: 0.094 SD: 0.110 SD: 0.0
CV: 1.03% CV: 0.0% CV: 0.33% CV: 0.4% CV: 0.0%
M. kansasii (375 cp/ml) SD: 0.275 SD: 0.125 SD: 0.120 SD: 0.108 SD: 0.070
CV: 0.88% CV: 0.4% CV: 0.39% CV: 0.3% CV: 0.22%
M. kansasii (3750 cp/ml) SD: 0.214 SD: 0.090 SD: 0.148 SD: 0.0 SD: 0.0
CV: 0.74% CV: 0.31% CV: 0.51% CV: 0.0% CV: 0.0%
MELTING TEMPERATURE
Reference Standard
Intra Run
Variability
Run to Run
Variability
Day to Day
Variability
Lot to Lot
Variability Lab to Lab Variability
Repeatability Intermediate Precision Reproducibility
M. tuberculosis (325 cp/ml) SD: 0.077 SD: 0.079 SD: 0.047 SD: 0.085 SD: 0.174
CV: 0.14% CV: 0.14% CV: 0.08% CV: 0.15% CV: 0.31%
M. tuberculosis (1625 cp/ml) SD: 0.070 SD: 0.089 SD: 0.0 SD: 0.088 SD: 0.150
CV: 0.12% CV: 0.16% CV: 0.0% CV: 0.2% CV: 0.27%
M. avium (488 cp/ml) SD: 0.061 SD: 0.085 SD: 0.0 SD: 0.050 SD: 0.168
CV: 0.12% CV: 0.17% CV: 0.0% CV: 0.1% CV: 0.34%
M. avium (4875 cp/ml) SD: 0.065 SD: 0.087 SD: 0.0 SD: 0.030 SD: 0.173
CV: 0.13% CV: 0.18% CV: 0.0% CV: 0.06% CV: 0.35%
M. kansasii (375 cp/ml) SD: 0.091 SD: 0.088 SD: 0.0 SD: 0.090 SD: 0.219
CV: 0.16% CV: 0.15% CV: 0.0% CV: 0.2% CV: 0.37%
M. kansasii (3750 cp/ml) SD: 0.104 SD: 0.076 SD: 0.0 SD: 0.100 SD: 0.212
CV: 0.18/% CV: 0.13% CV: 0.0% CV: 0.2% CV: 0.36%
Key: cp/ml: copies/microlitre SD: standard deviation and CV: coefficient of variance.
doi:10.1371/journal.pone.0024789.t002
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precision for the run to run, laboratory to laboratory, lot to lot,
day to day and intra-assay variance exceeded expected
outcomes with variability as low as 1% in the medium to high
concentration samples. The higher mean melting temperature
range (,0.3–0.4uC) observed in the Kimberley Laboratory
when compared to Pretoria could be attributed to the
instruments or other environmental parameters. It was also
noted that in a single sample from the 900 tested the Tm value
for M. tuberculosis in the Kimberley Laboratory overlapped the
lower specified Tm value for M. kansasii range. Adjustment of
the M. kansasii Tm range to accommodate this finding is
recommended.
The assay did not cross react with any of the non-
mycobacterial organisms tested nor was the assay inhibited by
the tested interfering substances. All but two of the tested
mycobacterial species cross-reacted within the Tm range of M.
avium and M. kansasii, however, no cross-reactivity occurred
within the Tm range for M. tuberculosis. The two mycobacterial
species detected by the challenge panel were M. scrofulaceum which
is usually isolated from lymph nodes and M. flavescens which has
been rarely isolated in humans [21]. The LightCyclerH
Mycobacterium Detection Kit proved to be specific for M.
tuberculosis, M. avium and M. kansasii which are clinically important
for respiratory infections especially in TB/HIV co-infection
settings. The test can further be improved to detect other
mycobacterial species based on their unique melting tempera-
tures. This would have a direct impact on the early and correct
management of the affected patients.
The LightCyclerH Mycobacterium Detection kit showed minimal
variance when applied using different operators and environments
highlighting its robustness. The overall, analytical performance
make this kit a candidate tool in the raoid diagnosis of tuberculosis.
Clinical evaluations in routine settings are required to validate its
performance.
Table 3. Mean and Standard Deviations for the different concentrations of the three Mycobacteria.
PRETORIA
Sample Concentration [copies/ml] Mean CP Standard Deviation CP Mean Tm Standard Deviation Tm
M. tuberculosis 13 31.65 0.471 56.59 0.260
M. tuberculosis 65 31.55 0.357 56.45 0.128
M. tuberculosis 325 30.40 0.307 56.26 0.129
M. tuberculosis 1625 27.97 0.260 56.22 0.107
M. avium 48.75 31.80 1.087 49.56 0.126
M. avium 487.5 30.68 0.320 49.48 0.103
M. avium 4875 28.23 0.280 49.43 0.122
M. kansasii 37.5 32.13 0.406 59.41 0.174
M. kansasii 375 31.06 0.277 58.65 0.135
M. kansasii 3750 28.87 0.265 58.49 0.148
KIMBERLEY
Sample Concentration [copies/ml] Mean CP Standard Deviation CP Mean Tm Standard Deviation Tm
M. tuberculosis 13 32.60 0.715 56.21 0.193
M. tuberculosis 65 32.09 0.462 56.07 0.131
M. tuberculosis 325 30.72 0.480 55.95 0.131
M. tuberculosis 1625 28.17 0.247 55.95 0.124
M. avium 48.75 32.37 0.948 49.25 0.141
M. avium 487.5 30.88 0.402 49.19 0.126
M. avium 4875 28.28 0.287 49.15 0.110
M. kansasii 37.5 32.88 0.478 58.96 0.165
M. kansasii 375 31.29 0.356 58.27 0.133
M. kansasii 3750 28.84 0.283 58.11 0.138
CP=crossing point TM=melt temperature.
doi:10.1371/journal.pone.0024789.t003
Figure 2. Pooled Melting Temperature (Tm) range of the M.
tuberculosis (MycoT), M. avium (MycoA) and M. kansasii (MycoK).
doi:10.1371/journal.pone.0024789.g002
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